Company / Operating Income
Tango Therapeutics, Inc. Operating Income History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$111.3M
FY2025
5-year range
-$145.6M / -$52.2M
FY2021-FY2025
Trend
+23.6%
vs FY2024
Sector context
#99 of 204
Health Care
What the data says
At -$111M, Tango Therapeutics, Inc.'s operating income ranks #99 of 204 in the Health Care sector. Operating Income returned to growth in FY2025 after 3 years of decline, reaching -$111M.
Based on SEC 10-K filings.
-$111M in FY2025.
Improved from -$114M to -$111M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#99 of 204 in Health CareTop 49% of 204This company -$111.3M Sector average $107.7M
▼
-203.3% below sector average
Key checks
Key Insights
- In FY2025, operating income increased 23.6% year-over-year.
- Ranks #99 out of 204 companies in the Health Care sector.
- Peak operating income was recorded in FY2021.
- Lowest operating income in the period was in FY2024.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$111.3M | +23.6% |
| FY2024 | -$145.6M | -27.5% |
| FY2023 | -$114.2M | -96.2% |
| FY2022 | -$58.2M | -11.5% |
| FY2021 | -$52.2M | +0.0% |
| FY2020 | -$52.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026